|Bid||78.58 x 800|
|Ask||78.72 x 900|
|Day's Range||76.69 - 78.76|
|52 Week Range||26.57 - 78.76|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||69.00|
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GOLETA, Calif., July 14, 2021--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
Investors are optimistic about Inogen's (INGN) direct-to-customer business model and a strong product portfolio.